Molecular characterization of the monoclonal antibodies composing ZMAb: A protective cocktail against ebola virus

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Audet, Jonathan ^a   Wong, Gary ^b   Wang, Han ^c   Lu, Guangwen ^c   Gao, George F ^c   Kobinger, Gary ^a,b,c,d   Qiu, Xiangguo ^b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b Public Health Agency of Canada   (Canada)

^c INSTITUTE OF MICROBIOLOGY   (China)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN ANTIBODY COMPLEX; EBOLA VACCINE; ENHANCED GREEN FLUORESCENT PROTEIN; ENVELOPE GLYCOPROTEIN, EBOLA VIRUS; EPITOPE; GREEN FLUORESCENT PROTEIN; HYBRID PROTEIN; MONOCLONAL ANTIBODY; VIRUS ANTIBODY; VIRUS ENVELOPE PROTEIN;

AMINO ACID SEQUENCE; ANIMAL; ANTAGONISTS AND INHIBITORS; ANTIGEN ANTIBODY COMPLEX; ANTIGEN ANTIBODY REACTION; BIOSYNTHESIS; CHEMICAL STRUCTURE; CHEMISTRY; EBOLAVIRUS; GENE EXPRESSION; GENETICS; HEMORRHAGIC FEVER, EBOLA; HUMAN; IMMUNE EVASION; IMMUNOLOGY; MOLECULAR GENETICS; MOUSE; MUTATION; REPORTER GENE; SEQUENCE ALIGNMENT; VESICULOVIRUS; VIROLOGY;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, VIRAL; ANTIGEN-ANTIBODY COMPLEX; ANTIGEN-ANTIBODY REACTIONS; EBOLA VACCINES; EBOLAVIRUS; EPITOPES; GENE EXPRESSION; GENES, REPORTER; GREEN FLUORESCENT PROTEINS; HEMORRHAGIC FEVER, EBOLA; HUMANS; IMMUNE EVASION; MICE; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUTATION; RECOMBINANT FUSION PROTEINS; SEQUENCE ALIGNMENT; VESICULOVIRUS; VIRAL ENVELOPE PROTEINS;

EID: 84922806645     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep06881     Document Type: Article

References (25)

1. Mehedi, M. et al. Anew Ebola virus nonstructural glycoprotein expressed through RNA editing. J. Virol. 85, 5406-14 (2011).
2. Lee, J. E. et al. Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor. Nature 454, 177-82 (2008).
3. Hood, C. L. et al. Biochemical and structural characterization of cathepsin Lprocessed Ebola virus glycoprotein: implications for viral entry and immunogenicity. J. Virol. 84, 2972-82 (2010).
4. Weissenhorn,W., Carfí, A., Lee, K. H., Skehel, J. J. &Wiley, D. C. Crystal structure of the Ebola virusmembrane fusion subunit, GP2, from the envelope glycoprotein ectodomain. Mol. Cell 2, 605-16 (1998).
5. Dye, J. M. et al. Postexposure antibody prophylaxis protects nonhuman primates from filovirus disease. Proc. Natl. Acad. Sci. U. S. A. 109, 5034-9 (2012).
6. Pettitt, J. et al. Therapeutic intervention of Ebola virus infection in rhesus macaques with the MB-003 monoclonal antibody cocktail. Sci. Transl. Med. 5, 199ra113 (2013).
7. Olinger, G. G. et al. Delayed treatment of Ebola virus infection with plant-derived monoclonal antibodies provides protection in rhesus macaques. Proc. Natl. Acad. Sci. U. S. A. 109, 18030-5 (2012).
8. Qiu, X. et al. Successful treatment of ebola virus-infected cynomolgus macaques with monoclonal antibodies. Sci. Transl. Med. 4, 138ra81 (2012).
9. Qiu, X. et al. mAbs and Ad-Vectored IFN-a Therapy Rescue Ebola-Infected Nonhuman Primates When Administered After the Detection of Viremia and Symptoms. Sci. Transl. Med. 5, 207ra143 (2013).
10. Marzi, A. et al. Protective efficacy of neutralizing monoclonal antibodies in a nonhuman primate model of Ebola hemorrhagic fever. PLoS One 7, e36192 (2012).
11. Qiu, X. et al. Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp. Nature 513 (2014).
12. Qiu, X. et al. Characterization of Zaire ebolavirus glycoprotein-specific monoclonal antibodies. Clin. Immunol. 141, 218-27 (2011).
13. Ye, J., Ma,N., Madden, T. L.&Ostell, J. M. IgBLAST: an immunoglobulin variable domain sequence analysis tool. Nucleic Acids Res. 41, W34-40 (2013).
14. Qiu, X. et al. Successful treatment of ebola virus-infected cynomolgus macaques with monoclonal antibodies. Sci. Transl. Med. 4, 138ra81 (2012).
15. Bale, S. et al. Structural basis for differential neutralization of ebolaviruses. Viruses 4, 447-70 (2012).
16. Qiu, X. et al. Sustained protection against Ebola virus infection following treatment of infected nonhuman primates with ZMAb. Sci. Rep. 3, 3365 (2013).
17. Qiu, X. et al. Ebola GP-Specific Monoclonal Antibodies Protect Mice and Guinea Pigs from Lethal Ebola Virus Infection. PLoS Negl. Trop. Dis. 6, e1575 (2012).
18. Marzi, A. et al. Protective efficacy of neutralizing monoclonal antibodies in a nonhuman primate model of Ebola hemorrhagic fever. PLoS One 7, e36192 (2012).
19. Wilson, J. A. Epitopes Involved in Antibody-Mediated Protection from Ebola Virus. Science (80-.). 287, 1664-1666 (2000).
20. Takada, A. et al. Identification of Protective Epitopes on Ebola Virus Glycoprotein at the Single Amino Acid Level by Using Recombinant Vesicular Stomatitis Viruses. J. Virol. 77, 1069-1074 (2003).
21. Garbutt, M. et al. Properties of Replication-Competent Vesicular Stomatitis Virus Vectors Expressing Glycoproteins of Filoviruses and Arenaviruses. J. Virol. 78, 5458-5465 (2004).
22. Tiller, T., Busse, C. E. & Wardemann, H. Cloning and expression of murine Ig genes from single B cells. J. Immunol. Methods 350, 183-93 (2009).
23. Ehrenmann, F., Kaas, Q. & Lefranc, M.-P. IMGT/3Dstructure-DB and IMGT/ DomainGapAlign: a database and a tool for immunoglobulins or antibodies, T cell receptors, MHC, IgSF and MhcSF. Nucleic Acids Res. 38, D301-7 (2010).
24. Rubinstein, N. D., Mayrose, I., Martz, E. & Pupko, T. Epitopia: a web-server for predicting B-cell epitopes. BMC Bioinformatics 10, 287 (2009).
25. Maruyama, T. et al. Ebola virus can be effectively neutralized by antibody produced in natural human infection. J. Virol. 73, 6024-30 (1999).